ArticleClinical and experimental nephrology2026
Comparison of renal outcomes between sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide 1 receptor agonist in Japanese patients with type 2 diabetes and obesity.
Yukihiro Wada et al.PubMed ↗Publisher ↗
No numbers read from the abstract.